| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Research and development expenses | 235,992 | |||
| General and administrative expenses | 287,922 | |||
| Total operating expenses | 523,914 | |||
| Interest income | 448 | |||
| Other expense, net | 136,565 | |||
| Total other expense, net | 137,013 | |||
| Loss before tax expense | -386,901 | |||
| Net loss | -386,901 | |||
| Foreign currency translation gain, net of taxes | -86,539 | |||
| Total comprehensive loss | -473,440 | |||
| Basic (in dollars per share) | -0.02 | |||
| Basic (in shares) | 21,640,000 | |||
| Diluted (in dollars per share) | -0.02 | |||
| Diluted (in shares) | 21,640,000 | |||
Advanced Biomed Inc. (ADVB)
Advanced Biomed Inc. (ADVB)